Objective: Permanent cardiac pacing in children and adolescents is rare and
often occurs by means of epicardial pacing. Based on two decades of experi
ence, operative and postoperative data of patients with epicardial and tran
svenous pacing were analyzed retrospectively. Methods: Between October 1979
and December 1998, 71 patients (mean age, 5.3 +/- 4.2, range, 1 day-16.2 y
ears; mean body weight, 18 +/- 12; range, 8-56 kg) underwent permanent pace
maker implantation. Indications were sinus node dysfunction and atrio-ventr
icular block following surgery for congenital heart disease (69%), or conge
nital atrioventricular block (31%). Pacing was purely atrial (1.4%), purely
ventricular (73%), ventricular with atrial synchronization (5.6%), or atri
oventricular synchronized (20%). Epicardial pacing was established in 49 (6
9%), transvenous in 22 (31%) patients. Follow-up was 3.4 +/- 3.8 years (epi
cardial) and 3.0 +/- 4.0 years (transvenous). Results: Epicardial leads wer
e implanted in younger patients (mean age: 4.5 vs. 7.0 years, P < 0.05) and
preferably after surgery induced atrioventricular block (78 vs. 46%, P < 0
.05). The youngest patient with transvenous pacing was 1.3 years old (weigh
t, 8.5 kg). At implantation epicardial ventricular stimulation threshold at
1.0 ms was 1.07 +/- 0.46 vs. 0.53 +/- 0.31 V (transvenous) (P < 0.05). The
age-adjusted rate of lead-related reoperations was significantly higher in
patients with epicardial leads (P < 0.05), mainly due to increasing chroni
c stimulation thresholds resulting in early battery depletion. In three pat
ients who received steroid-eluting epicardial leads initial low thresholds
persisted after five month to one years. In two patients with recurrent epi
cardial threshold increase, steroid-eluting epicardial leads led to good ac
ute and chronic thresholds after nine to 15 month. Two post-operative death
(2.8%) were probably due to a dysfunction of the (epicardial) pacing syste
m. Conclusions: Transvenous pacing in the pediatric population is associate
d with a lower acute stimulation threshold and a lower rate of lead-related
complications. If epicardial pacing is necessary (e.g. small body weight,
special intracardiac anatomy (e.g. Fontan), impossible access to superior c
aval vein), steroid-eluting leads may be considered. (C) 2000 Elsevier Scie
nce B.V. Ail rights reserved.